[Cardiovascular pharmacotherapy in old age: How beneficial is it? What does it cost?]
[Article in
German]
Affiliations
- PMID: 7491446
Item in Clipboard
[Cardiovascular pharmacotherapy in old age: How beneficial is it? What does it cost?]
[Article in
German]
Praxis (Bern 1994).
.
Abstract
Because of their high morbidity and mortality, elderly people benefit most from drugs with a proven effect on disease complications and premature death. Thiazides, beta adrenergic blocking drugs, oral anticoagulants and aspirin are drugs that satisfy such criteria. These medications are comparatively well tolerated and cheap. They should not be neglected in favour of newer drugs with a less complete performance record.
Similar articles
-
Cardiovascular drug therapy in the elderly.Cardiol Rev. 2007 Jul-Aug;15(4):195-215. doi: 10.1097/CRD.0b013e3180301b69. Cardiol Rev. 2007. PMID: 17575484 Review.
-
The effect of ACE inhibitors on cardiovascular morbidity and mortality.J Fam Pract. 1999 Jun;48(6):414-5. J Fam Pract. 1999. PMID: 10386477 No abstract available.
-
Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.J Hum Hypertens. 2003 Apr;17(4):277-85. doi: 10.1038/sj.jhh.1001538. J Hum Hypertens. 2003. PMID: 12714973
-
[Are the newer antihypertensive agents better and more effective than diuretics?].Tidsskr Nor Laegeforen. 2001 Feb 28;121(6):701-5. Tidsskr Nor Laegeforen. 2001. PMID: 11293353 Review. Norwegian.
-
Merck Serono targets convenient, affordable medicines for patients at risk.Cardiovasc J Afr. 2009 Jan-Feb;20(1):77. Cardiovasc J Afr. 2009. PMID: 19287822 No abstract available.